MELISSA GIRARD: Open Payments
NPI 1801254966 · BLANCHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 23 payments from 16 companies in 2025. Trend: 2023 $589 · 2024 $777 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Novo Nordisk Inc | 2 | $35 |
| Exact Sciences Corporation | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: UBRELVY, CAPLYTA, Ozempic, AIRSUPRA, Cologuard Collection Kit, NURTEC ODT, REXULTI, NEXLETOL.
Industry payments across OH — which companies pay providers there.
